Genome-Editing Products Line up for the Market: Will Europe Harvest the Benefits from Science and Innovation?

Genes (Basel). 2024 Aug 1;15(8):1014. doi: 10.3390/genes15081014.

Abstract

Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) technologies have revolutionized genome editing, significantly advancing the improvement of cultivated crop species. This review provides an overview of genome-edited crops that have either reached the market or received the necessary approvals but are not yet available to consumers. We analyze various genome-editing studies to understand the distribution of different genome-editing systems, the types of site-directed nucleases employed, and the geographical spread of these studies, with a specific focus on global and European contexts. Additionally, we examine the target crops involved. The review also outlines the multiple steps required for the legal acceptance of genome-edited crops within European jurisdictions. We conclude with suggestions for the future prospects of genome-editing research in Europe, aiming to streamline the approval process and enhance the development and adoption of genome-edited crops.

Keywords: CRISPR; European Union (EU) regulation; Genetically Modified Organisms (GMOs); New Genomic Techniques (NGTs); crop improvement; product commercialization.

Publication types

  • Review

MeSH terms

  • CRISPR-Cas Systems*
  • Crops, Agricultural* / genetics
  • Crops, Agricultural* / growth & development
  • Europe
  • Gene Editing* / methods
  • Genome, Plant
  • Humans
  • Plants, Genetically Modified* / genetics

Grants and funding

This research received no external funding.